Clinical Trial Update: Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma

View source ↗

Summary

Clinical trial update reporting on analysis of molecular markers related to drug resistance in tumor biopsies from patients with previously untreated aggressive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Non-Hodgkin Lymphoma | Status: COMPLETED